CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 4, 1999, Pages 498-509

  Mathur, Mudit ^b   Herrmann, Karin ^b   Qin, Yimin ^b   Gulmen, Funda ^b   Li, Xiantang ^b   Krimins, Rebecca ^b   Weinstock, Joel ^b   Elliott, David ^b   Bluestone, Jeffrey A ^b   Padrid, Philip ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE; SCHISTOSOMA MANSONI;

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; IMMUNOGLOBULIN E; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; PRIMER DNA;

ANIMAL; ARTICLE; ASTHMA; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; EOSINOPHILIA; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; SCHISTOSOMA MANSONI;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, HELMINTH; ASTHMA; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; EOSINOPHILIA; FEMALE; IMMUNOGLOBULIN E; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SCHISTOSOMA MANSONI;

EID: 0033210753     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.4.3714     Document Type: Article

References (42)

1. NIH Program. 1997. Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Bethesda, MD.
2. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and GM CSF in bronchial biopsies after allergen inhalation in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
3. Berman, J. S., and P. F. Weller. 1992. Airway lymphocytes and eosinophils in asthma. Am. Rev. Respir. Dis. 145:1246-1248.
4. Gemou-Engasacth, V., A. B. Kay, A. Bush, and C. J. Corrigan. 1994. Activated peripheral blood CD4 and CD8 T-lymphocytes in child asthma: correlation with eosinophilia and disease severity. Pediatr. Allergy Immunol. 5:170-177.
5. Sperling, A., and J. Bluestone. 1996. The complexities of T-cell co-stimula tion: CD28 and beyond. Immunol. Rev. 153:155-182.
6. Keane-Myers, A., W. C. Gause, P. S. Linsley, S. J. Chen, and M. Wills-Karp. 1997. B7 CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042-2049.
7. Krinzman, S. J., G. T. De Sanetis, M. Cernadas, D. Mark, Y. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, D. C. Christiani, D. L. Perkins, and P. W. Finn. 1996. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98:2693-2699.
8. Padrid, P. A., M. Mathur, X. Li, K. Herrmann, Y. Qin, A. Cattamanchi, J. Weinstock, D. Elliott, A. I. Sperling, and J. A. Bluestone. 1998. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 18:453-462.
9. Van Oosterhout, A. J., C. L. Hofstra, R. Shields, B. Chan, I. Van Ark, P. M. Jardieu, and F. P. Nijkamp. 1997. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulalion in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 17:386-392.
10. Lin, H., J. C. Rathmell, G. S. Gray, C, H. Thompson, J. M. Leiden, and M. L. Alegre. 1998. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts, in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188: 199-204.
11. Pearson, T. C., D. Z. Alexander, M. Corbascio, R. Hendrix, S. C. Ritchic, P. S. Linsley, D. Faherty, and C. P. Larsen. 1997. Analysis of the B7 co-stimulatorv pathway in allograft rejection. Transplantation 63:1463-1469.
12. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K, Kishihari, A. Wakeham, K. Kawai, P. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulalory requirements in CD28-deficient mice. Science 261:609-612.
13. Razi-Wolf, Z., F. Galvin, G. Gray, and H. Reiser. 1993. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc. Natl. Acad. Sci. USA 90:11182-11186.
14. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes, 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905-907.
15. Lenschow, D. J., Y. Zeng, K. Hathcock, L. A. Zuckcrman, G. Freeman, J. R. Thistlethwaite, T. A. Barrett, G. S. Gray, J. Miller, R. J. Hodes, and J. A. Bluestone. 1995. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-I antibodies. Transplantation 60:1171-1178.
16. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374-1378.
17. Elliott, D. E. 1996. Methods used to study immunoregulation of schistosome egg granulomas. Immunol. Methods 9:255-267.
18. Zar, J. 1984. Biostatistical Analysis, 2nd ed. Prentice Hall, Englewood Cliffs, N.J.
19. Greenfield, E. A., E. Howard, T. Paradis, K. Nguyen, F. Benazzo, P. McLean, P, Hollsberg, G. Davis, D. A. Hafler, A. H. Sharpe, G. J. Freeman, and V. K. Kuchroo. 1997. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity bill retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J. Immunol. 158:2025-2034.
20. Rulifson I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158:658-665.
21. Vanderlugt, C. L., W. S. Begolka, K. L. Neville, Y. Katz-Levy, L. M. Howard, T. N. Eagar, J. A. Bluestone, and S. D. Miller. 1998. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164:63-72.
22. Harris, N., R. Peach, J. Naemura, P. S. Linsley, G. Le Gros, and F. Ronehese. 1997. CDSO costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 185:177-182.
23. Keane-Myers, A. M., W. C. Gause, F. D. Finkelman, X. D. Xhou, and M. Wills-Karp. 1998. Development of murine allergic asthma is dependent upon B7-2 costimulation. J. Immunol. 160:1036-1043.
24. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyte. 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airway responsiveness. J. Exp. Med. 185:1671-1679.
25. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793-801.
26. Tamura, N., N. Ishii, M. Nakazawa, M. Nagoya, M. Yoshinari, T. Amano, H. Nakazima, and M. Minami. 1996. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand. J. Immunol. 44:229-238.
27. Brown, D. R., J. M. Green, N. H. Moskowitz, M. Davis, C. B. Thompson, and S. L., Reiner. 1996. Limited role of CD28 mediated signals in T helper subset differentiation. J. Exp. Med. 184:803-810.
28. Sperling, A. I., P. S. Linsley, T. A. Barrett, and J. A. Bluestone. 1993. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta 1 T lymphocytes. J. Immunol. 151:6043-6050.
29. Cibotti, R., J. A. Punt, K. S. Dash, S. O. Sharrow, and A. Singer. 1997. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity 6:245-255.
30. Walunas, T. L., A. I. Sperling, R. Khattri, C. B. Thompson, and J. A. Bluestone. 1996. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156:1006-1013.
31. August, A., S. Gibson, Y. Kawakami, T. Kawakami, G. B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA 91:9347-9351.
32. Crooks, M. E., D. R. Littman, R, H. Carter, D. T. Fearon, A. Weiss, and P. H. Stein. 1995. CD28-mediated coslimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell. Biol. 15:6820-6828.
33. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. E. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
34. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155.
35. Miller, S. D., C. L. Vanderlugt, D. J. Lensehow, J, G. Pope, N. J. Karandikar, M. C. D. Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-I interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739-745.
36. Masten, B., J. Yates, A. P. Koga, and M. Lipscomh. 1997. Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, and CD40L. Am. J. Respir. Cell Mol. Biol. 16:335-342.
37. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90:11059-11063.
38. Issazadeh, S., V. Navikas, M. Schaub, M. Sayegh, and S. Khoury. 1998. Kineties of expression of costimulatory molecutes and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104-1112.
39. Schweitzer, A. N., F. Borriello, R. C. Wong, A. K. Abbas, and A. H. Sharpe. 1997. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158: 2713-2722.
40. Greenwald, R. J., P. Lu, M. J. Halvorson, X. Zhou, S. Chen, K. B. Madden, P. J. Perrin, S. C. Morris, F. D. Finkelman, R. Peach, P. S. Linsley, J. F. Urban, Jr., and W. C. Gause. 1997. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158:4088-4096.
41. Han, S., K. Hathcock, B. Zheng, T. B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol. 155:556-567.
42. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol. 25:3060-3069.